[{"address1": "4000 Shoreline Court", "address2": "Suite 300", "city": "South San Francisco", "state": "CA", "zip": "94080", "country": "United States", "phone": "650 822 5600", "website": "https://www.kezarlifesciences.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases in the United States. The company's lead product candidate is zetomipzomib (KZR-616), a selective immunoproteasome inhibitor for various indications, including lupus nephritis, dermatomyositis, and polymyositis; and Phase 1b/2 clinical trials in systemic lupus erythematosus. It is also developing KZR-261, a novel first-in-class protein secretion inhibitor for the treatment of tumors resistant to traditional chemotherapeutics. Kezar Life Sciences, Inc. was incorporated in 2015 and is headquartered in South San Francisco, California.", "fullTimeEmployees": 55, "companyOfficers": [{"maxAge": 1, "name": "Dr. Christopher J. Kirk Ph.D.", "age": 52, "title": "Co-Founder, CEO & Director", "yearBorn": 1972, "fiscalYear": 2024, "totalPay": 927300, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. John Franklin Fowler", "age": 52, "title": "Co-Founder & Director", "yearBorn": 1972, "fiscalYear": 2024, "totalPay": 57037, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Marc L. Belsky CPA", "age": 69, "title": "CFO & Secretary", "yearBorn": 1955, "fiscalYear": 2024, "totalPay": 653208, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Mark  Schiller", "age": 44, "title": "Chief Operations Officer", "yearBorn": 1980, "fiscalYear": 2024, "totalPay": 637985, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Jack  Taunton Ph.D.", "title": "Co-Founder", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Pattie  Chiang", "age": 62, "title": "Principal Accounting Officer, Senior VP & Corporate Controller", "yearBorn": 1962, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Joe  Tedrick", "title": "Vice President of Human Resources", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Neel K. Anand Ph.D.", "title": "Senior Vice President of Research & Drug Discovery", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Zung  To", "title": "Chief Development Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Rachel  Peterson FACR, M.D.", "title": "Head of Clinical Immunology", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 7, "boardRisk": 9, "compensationRisk": 10, "shareHolderRightsRisk": 10, "overallRisk": 10, "governanceEpochDate": 1759276800, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 6.15, "open": 6.2, "dayLow": 6.0606, "dayHigh": 6.2, "regularMarketPreviousClose": 6.15, "regularMarketOpen": 6.2, "regularMarketDayLow": 6.0606, "regularMarketDayHigh": 6.2, "payoutRatio": 0.0, "beta": 0.621, "forwardPE": -0.5883476, "volume": 94215, "regularMarketVolume": 94215, "averageVolume": 168603, "averageVolume10days": 859900, "averageDailyVolume10Day": 859900, "bid": 6.1, "ask": 6.21, "bidSize": 1, "askSize": 1, "marketCap": 45110332, "fiftyTwoWeekLow": 3.53, "fiftyTwoWeekHigh": 8.45, "allTimeHigh": 363.3, "allTimeLow": 3.53, "fiftyDayAverage": 4.2226, "twoHundredDayAverage": 4.7609, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -43665668, "profitMargins": 0.0, "floatShares": 4314261, "sharesOutstanding": 7323106, "sharesShort": 764048, "sharesShortPriorMonth": 762155, "sharesShortPreviousMonthDate": 1757894400, "dateShortInterest": 1760486400, "sharesPercentSharesOut": 0.1043, "heldPercentInsiders": 0.10569999, "heldPercentInstitutions": 0.63956, "shortRatio": 15.94, "shortPercentOfFloat": 0.1066, "impliedSharesOutstanding": 7323106, "bookValue": 12.546, "priceToBook": 0.49099314, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -70791000, "trailingEps": -9.7, "forwardEps": -10.47, "lastSplitFactor": "1:10", "lastSplitDate": 1730246400, "enterpriseToEbitda": 0.584, "52WeekChange": -0.19999999, "SandP52WeekChange": 0.16625166, "quoteType": "EQUITY", "currentPrice": 6.16, "targetHighPrice": 7.0, "targetLowPrice": 5.0, "targetMeanPrice": 6.0, "targetMedianPrice": 6.0, "recommendationMean": 3.0, "recommendationKey": "hold", "numberOfAnalystOpinions": 2, "totalCash": 100849000, "totalCashPerShare": 13.771, "ebitda": -74738000, "totalDebt": 12073000, "quickRatio": 7.159, "currentRatio": 7.289, "debtToEquity": 13.153, "returnOnAssets": -0.32759, "returnOnEquity": -0.58391, "grossProfits": -54035000, "freeCashflow": -42026000, "operatingCashflow": -64304000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "KZR", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "corporateActions": [], "postMarketTime": 1761345381, "regularMarketTime": 1761336001, "longName": "Kezar Life Sciences, Inc.", "exchange": "NCM", "messageBoardId": "finmb_304157325", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "shortName": "Kezar Life Sciences, Inc.", "regularMarketChangePercent": 0.162598, "regularMarketPrice": 6.16, "marketState": "CLOSED", "postMarketChangePercent": -0.162334, "postMarketPrice": 6.15, "postMarketChange": -0.00999975, "regularMarketChange": 0.00999975, "regularMarketDayRange": "6.0606 - 6.2", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 168603, "fiftyTwoWeekLowChange": 2.6299999, "fiftyTwoWeekLowChangePercent": 0.74504244, "fiftyTwoWeekRange": "3.53 - 8.45", "fiftyTwoWeekHighChange": -2.29, "fiftyTwoWeekHighChangePercent": -0.27100593, "fiftyTwoWeekChangePercent": -19.999998, "earningsTimestampStart": 1763150400, "earningsTimestampEnd": 1763150400, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -9.7, "epsForward": -10.47, "epsCurrentYear": -7.05667, "priceEpsCurrentYear": -0.8729329, "fiftyDayAverageChange": 1.9373999, "fiftyDayAverageChangePercent": 0.45881683, "twoHundredDayAverageChange": 1.3990998, "twoHundredDayAverageChangePercent": 0.29387298, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "3.0 - Hold", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1529587800000, "displayName": "Kezar Life Sciences", "trailingPegRatio": null, "__fetch_time": "2025-10-25"}]